PROGRAM FOR THE FUNDAMENTAL IMPROVEMENT OF PHARMACOEPIDEMIOLOGY, PREVENTION, AND TREATMENT METHODS FOR POST-COVID-19-ASSOCIATED DIGESTIVE SYSTEM DISEASES

Authors

  • Boltaboyev Alisher Murodiljon oʻgʻli Assistant, Department of Internal Medicine No. 1, Central Asian Medical University Cardiologist and Head of the Cardiology Department, Meridian Diagnostic Hospital Fergana, Uzbekistan Author

Keywords:

post-COVID-19 condition; digestive system diseases; pharmacoepidemiology; pharmacotherapeutic compliance; regional program.

Abstract

Pharmacotherapy was audited in 1,605 COVID-19 survivors aged 48-60 years in Fergana. Treatment met clinical standards in 87.8% of women and 65.1% of men (p<0.001). A multi-component program raised diagnostic and treatment effectiveness from 50.0% to 100.0%.

Downloads

Published

2026-10-25